{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:26:14Z","timestamp":1787757974158,"version":"build-2784847793"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.4103\/aian.aian_427_22","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T01:05:08Z","timestamp":1655168708000},"page":"330-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19-Associated Mucormycosis"],"prefix":"10.4103","volume":"25","author":[{"given":"Rahul","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240828","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/aian.aian_463_21","article-title":"Rhino-orbito-cerebral mycosis and COVID-19: From bad to worse?","volume":"25","author":"Kulkarni","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"R2-2-20240828","doi-asserted-by":"crossref","first-page":"102267","DOI":"10.1016\/j.dsx.2021.102267","article-title":"COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum?","volume":"15","author":"Dubey","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R3-2-20240828","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India?","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R4-2-20240828","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India-Collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R5-2-20240828","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4103\/aian.aian_1097_21","article-title":"Covid-19 and mucormycosis superinfection: Prospective, obsevational study in a single center","volume":"25","author":"Garg","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"R6-2-20240828","first-page":"100057","article-title":"Mucormycosis in COVID-19 pandemic: Risk factors and linkages?","volume":"2","author":"Kumar","year":"2021","journal-title":"Curr Res Microb Sci"},{"key":"R7-2-20240828","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijid.2021.08.037","article-title":"Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic","volume":"111","author":"Bhanuprasad","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R9-2-20240828","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2021.12.039","article-title":"Risk factors for Coronavirus disease-associated mucormycosis","volume":"84","author":"Arora","year":"2022","journal-title":"J Infect"},{"key":"R10-2-20240828","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"R11-2-20240828","doi-asserted-by":"crossref","first-page":"106231","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106231","article-title":"Cerebrovascular involvement in mucormycosis in COVID-19 pandemic?","volume":"31","author":"Kulkarni","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R12-2-20240828","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.crad.2021.07.002","article-title":"Imaging findings using a combined MRI\/CT protocol to identify the \u201centire iceberg\u201d in post-COVID-19 mucormycosis presenting clinically as only \u201cthe tip\u201d","volume":"76","author":"Desai","year":"2021","journal-title":"Clin Radiol"},{"key":"R13-2-20240828","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R14-2-20240828","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/aian.AIAN_421_21","article-title":"Epidemic of mucormycosis in COVID-19 pandemic: A position paper","volume":"25","author":"Kulkarni","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"R15-2-20240828","doi-asserted-by":"crossref","first-page":"e01184","DOI":"10.1128\/AAC.01184-19","article-title":"Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis","volume":"63","author":"Barde","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-2-20240828","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myz103","article-title":"Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system","volume":"58","author":"Schwartz","year":"2020","journal-title":"Med Mycol"},{"key":"R17-2-20240828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J Fungi (Basel"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_427_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:00:22Z","timestamp":1787756422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_427_22"}},"subtitle":["What Neurologists Should Know?"],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_427_22","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}